Axiolabs Tamoxiplex contains Tamoxifen Citrate in oral tablet form, labeled at 20 mg per tablet. For tablet-based formulations, independent lab testing is useful for confirming the actual active substance content and evaluating how closely a batch matches its labeled dosage.
Below is the latest available lab test confirming the potency of Tamoxiplex 20 mg, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-20
- Product: Tamoxiplex
- Active Substance: Tamoxifen Citrate
- Manufacturer: Axiolabs
- Labeled Dosage: 20 mg/tablet
- Result: 19.13 mg/tablet
- Laboratory: Janoshik
This lab test shows a measured content of 19.13 mg per tablet, which is close to the labeled 20 mg dosage. The result indicates good formulation accuracy with a small negative deviation.
Potency Analysis
- Labeled dosage: 20 mg
- Measured dosage: 19.13 mg
- Deviation: ~-4.4%
- Laboratory: Janoshik
The measured result shows only a minor deviation from the labeled dosage, remaining within a tight range for a tablet formulation.
About Tamoxiplex (Tamoxifen Citrate)
Tamoxifen Citrate is commonly produced in oral tablet form, where consistent dosing is important for batch reliability. Independent lab testing provides transparency by showing how closely the measured content matches the labeled strength.
This type of verification is especially useful for assessing real-world manufacturing accuracy across individual batches.
Conclusion
The available lab test for Axiolabs Tamoxiplex 20 mg shows a measured dosage of 19.13 mg per tablet, which is close to the labeled amount. This result reflects good formulation accuracy with a relatively small negative deviation.
As only one report is currently available, additional lab tests over time would provide a clearer view of long-term batch consistency. However, this initial result indicates a reliable potency profile.
Frequently Asked Questions
Yes, the available lab test shows 19.13 mg per tablet, which is close to the labeled 20 mg dosage.
The measured result is approximately 4.4% below the labeled dosage.
The available lab report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports would help evaluate consistency across batches.
